Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Roche Launches New BenchMark ULTRA PLUS System for Cancer Diagnostics Enabling Timely, Targeted Patient Care
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the BenchMark ULTRA PLUS system, its […]
Roche Launches Human Papillomavirus (HPV) Self-sampling Solution, Expanding Cervical Cancer Screening Options
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of a human papillomavirus (HPV) […]
Roche Develops Unique PCR Tests to Detect the Monkeypox Virus
Roche (SIX: RO, ROG; OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed three unique LightMix® Modular Virus […]
Roche Enters Partnership With the Global Fund to Support Low- and Middle-income Countries in Strengthening Critical Diagnostics Infrastructure
Roche (SIX: RO, ROG; OTCQX: RHHBY), through its Global Access Program, and The Global Fund […]
Roche Provides Molecular Testing Solutions to Identify and Differentiate SARS-CoV-2 Omicron Variants of Concern
Roche (SIX: RO, ROG; OTCQX: RHHBY) and TIB Molbiol, a subsidiary within the Roche Diagnostics division, […]
Roche Launches the Cobas® Pulse System, an Industry First Professional Blood Glucose Management Solution with Mobile Digital Health Capabilities to Improve Patient Care
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® pulse system in […]
Significant Investment Accelerates Freenome's Multiomics Platform for the Early Detection of Cancer
Freenome, a privately held biotech company, announced today that Roche has made an investment of $290 […]
Roche Introduces Cobas Infinity Edge, a New Open Digital Ecosystem for Point of Care Professionals, Driving Improved Patient Outcomes and Operational Efficiencies in Healthcare
Roche (SIX: RO, ROG; OTCQX: RHHBY) today introduced cobas ® infinity edge, a secure and […]
Roche Launches the AVENIO Edge System to Simplify and Automate Next-generation Sequencing Sample Preparation, Reduce Human Error and Advance Precision Medicine
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the AVENIO Edge System, […]
Roche to Launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in Countries Accepting the CE Mark to Enable Rapid Differentiation of Viral Respiratory Infections
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more